Sigmoidoscopy
Sponsors
Bonderup, Ole K., M.D., Cosmo Technologies Ltd, Sidney Kimmel Cancer Center at Thomas Jefferson University, Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Conditions
AIDS-Related Anal CarcinomaAbsence of Signs or SymptomsAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell CarcinomaAnal Squamous Cell CarcinomaB-Cell Non-Hodgkin Lymphoma
Phase 1
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
WithdrawnNCT00960427
Start: 2009-06-30End: 2010-04-30Updated: 2013-04-16
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
RecruitingNCT05630794
Start: 2025-10-06End: 2028-03-01Target: 36Updated: 2026-04-03
Phase 2
Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy
CompletedNCT00867438
Start: 2007-01-31End: 2007-11-30Updated: 2009-03-25
FMT in Ulcerative Colitis-Associated Pouchitis
CompletedNCT02049502
Start: 2014-07-31End: 2018-02-01Updated: 2019-03-27
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
Active, not recruitingNCT04751370
Start: 2022-02-08End: 2026-12-31Target: 31Updated: 2026-04-03
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Active, not recruitingNCT04929028
Start: 2022-08-09End: 2031-09-15Target: 40Updated: 2026-04-03
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
Active, not recruitingNCT05610163
Start: 2022-12-08End: 2033-09-30Updated: 2025-09-08
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
RecruitingNCT06780787
Start: 2025-05-20End: 2027-11-05Target: 26Updated: 2025-06-26
Phase 3
Long-Term Treatment of Collagenous Colitis With Budesonide
NCT00139165
Start: 2004-09-30End: 2006-03-31Target: 36Updated: 2008-03-06
Increasing Colorectal Cancer Screening in African Americans
NCT00893295
Start: 2008-02-29Target: 896Updated: 2013-12-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Active, not recruitingNCT03233711
Start: 2018-07-05End: 2027-12-31Target: 344Updated: 2026-04-03
Unknown Phase
Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)
Active, not recruitingNCT01696981
Start: 1993-11-16End: 2026-03-25Updated: 2025-07-23
The Altitude Inflammatory Bowel Disease Study
NCT02849821
Start: 2014-05-31End: 2016-12-31Updated: 2016-07-29
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
TerminatedNCT02928510
Start: 2016-02-01End: 2018-06-05Updated: 2021-07-14
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis
Active, not recruitingNCT03955510
Start: 2016-07-31End: 2026-05-31Updated: 2025-10-28
Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease
CompletedNCT05209100
Start: 2022-02-11End: 2023-03-22Updated: 2026-04-03
Fecal Microbiota Transplantation for Patients With Chronic Widespread Pain
SuspendedNCT05700331
Start: 2025-01-31End: 2026-01-31Target: 20Updated: 2023-08-30